Isolated portal vein involvement in pancreatic adenocarcinoma

A contraindication for resection?

Lawrence Harrison, David S. Klimstra, Murray F. Brennan

Research output: Contribution to journalArticle

267 Citations (Scopus)

Abstract

Objective: This study was designed to examine the morbidity, mortality, and survival of patients undergoing portal vein resection (PVR) for adenocarcinoma of the pancreas. Summary Background Data: Inability to separate the pancreas from the portal vein has historically been a locoregional contraindication for resection in patients with adenocarcinoma of the pancreas, and frequently, isolated local invasion of the portal vein is the only obstacle to curative resection. Methods: A review of the prospective database for adenocarcinoma of the pancreas at Memorial SloanKettering Cancer Center identified 332 patients who underwent pancreatic resection. Of those, 58 (17%) were identified as having isolated clinical involvement of the portal vein and underwent pancreatic resection with PVR. Patients undergoing curative pancreatic resection without PVR over this same time period comprise the control group. Results: The 5% in-hospital modality rate for PVR was not significantly different from that seen in those patients who did not undergo PVR (3%). Overall median survival for the PVR group was 13 months (range, < 1-109 months), which was not statistically different from those patients undergoing pancreatic resection without PVR (17 months (range, < 1-132months). Conclusions: These results suggest that suspected isolated portal vein involvement should not be a contraindication for pancreatic resection in patients with adenocarcinoma.

Original languageEnglish (US)
Pages (from-to)342-349
Number of pages8
JournalAnnals of Surgery
Volume224
Issue number3
DOIs
StatePublished - Sep 26 1996
Externally publishedYes

Fingerprint

Portal Vein
Adenocarcinoma
Pancreas
Survival
Databases
Morbidity
Control Groups
Mortality

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Harrison, Lawrence ; Klimstra, David S. ; Brennan, Murray F. / Isolated portal vein involvement in pancreatic adenocarcinoma : A contraindication for resection?. In: Annals of Surgery. 1996 ; Vol. 224, No. 3. pp. 342-349.
@article{4e6df86287b342b0a5136fd8a4a418e8,
title = "Isolated portal vein involvement in pancreatic adenocarcinoma: A contraindication for resection?",
abstract = "Objective: This study was designed to examine the morbidity, mortality, and survival of patients undergoing portal vein resection (PVR) for adenocarcinoma of the pancreas. Summary Background Data: Inability to separate the pancreas from the portal vein has historically been a locoregional contraindication for resection in patients with adenocarcinoma of the pancreas, and frequently, isolated local invasion of the portal vein is the only obstacle to curative resection. Methods: A review of the prospective database for adenocarcinoma of the pancreas at Memorial SloanKettering Cancer Center identified 332 patients who underwent pancreatic resection. Of those, 58 (17{\%}) were identified as having isolated clinical involvement of the portal vein and underwent pancreatic resection with PVR. Patients undergoing curative pancreatic resection without PVR over this same time period comprise the control group. Results: The 5{\%} in-hospital modality rate for PVR was not significantly different from that seen in those patients who did not undergo PVR (3{\%}). Overall median survival for the PVR group was 13 months (range, < 1-109 months), which was not statistically different from those patients undergoing pancreatic resection without PVR (17 months (range, < 1-132months). Conclusions: These results suggest that suspected isolated portal vein involvement should not be a contraindication for pancreatic resection in patients with adenocarcinoma.",
author = "Lawrence Harrison and Klimstra, {David S.} and Brennan, {Murray F.}",
year = "1996",
month = "9",
day = "26",
doi = "10.1097/00000658-199609000-00010",
language = "English (US)",
volume = "224",
pages = "342--349",
journal = "Annals of Surgery",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

Isolated portal vein involvement in pancreatic adenocarcinoma : A contraindication for resection? / Harrison, Lawrence; Klimstra, David S.; Brennan, Murray F.

In: Annals of Surgery, Vol. 224, No. 3, 26.09.1996, p. 342-349.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Isolated portal vein involvement in pancreatic adenocarcinoma

T2 - A contraindication for resection?

AU - Harrison, Lawrence

AU - Klimstra, David S.

AU - Brennan, Murray F.

PY - 1996/9/26

Y1 - 1996/9/26

N2 - Objective: This study was designed to examine the morbidity, mortality, and survival of patients undergoing portal vein resection (PVR) for adenocarcinoma of the pancreas. Summary Background Data: Inability to separate the pancreas from the portal vein has historically been a locoregional contraindication for resection in patients with adenocarcinoma of the pancreas, and frequently, isolated local invasion of the portal vein is the only obstacle to curative resection. Methods: A review of the prospective database for adenocarcinoma of the pancreas at Memorial SloanKettering Cancer Center identified 332 patients who underwent pancreatic resection. Of those, 58 (17%) were identified as having isolated clinical involvement of the portal vein and underwent pancreatic resection with PVR. Patients undergoing curative pancreatic resection without PVR over this same time period comprise the control group. Results: The 5% in-hospital modality rate for PVR was not significantly different from that seen in those patients who did not undergo PVR (3%). Overall median survival for the PVR group was 13 months (range, < 1-109 months), which was not statistically different from those patients undergoing pancreatic resection without PVR (17 months (range, < 1-132months). Conclusions: These results suggest that suspected isolated portal vein involvement should not be a contraindication for pancreatic resection in patients with adenocarcinoma.

AB - Objective: This study was designed to examine the morbidity, mortality, and survival of patients undergoing portal vein resection (PVR) for adenocarcinoma of the pancreas. Summary Background Data: Inability to separate the pancreas from the portal vein has historically been a locoregional contraindication for resection in patients with adenocarcinoma of the pancreas, and frequently, isolated local invasion of the portal vein is the only obstacle to curative resection. Methods: A review of the prospective database for adenocarcinoma of the pancreas at Memorial SloanKettering Cancer Center identified 332 patients who underwent pancreatic resection. Of those, 58 (17%) were identified as having isolated clinical involvement of the portal vein and underwent pancreatic resection with PVR. Patients undergoing curative pancreatic resection without PVR over this same time period comprise the control group. Results: The 5% in-hospital modality rate for PVR was not significantly different from that seen in those patients who did not undergo PVR (3%). Overall median survival for the PVR group was 13 months (range, < 1-109 months), which was not statistically different from those patients undergoing pancreatic resection without PVR (17 months (range, < 1-132months). Conclusions: These results suggest that suspected isolated portal vein involvement should not be a contraindication for pancreatic resection in patients with adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0029816521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029816521&partnerID=8YFLogxK

U2 - 10.1097/00000658-199609000-00010

DO - 10.1097/00000658-199609000-00010

M3 - Article

VL - 224

SP - 342

EP - 349

JO - Annals of Surgery

JF - Annals of Surgery

SN - 0003-4932

IS - 3

ER -